Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryosuke Nakano

Showing results (31-40 of 94) with videos related to

Pageof 10
Sort By:
Transplant Immunology|November 5, 2024
Association of PIRCHE-II score with anti-donor T-cell response and risk of de novo donor-specific antibody production in kidney transplant recipientsHiroaki Yamane, Kentaro Ide, Yuka Tanaka, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|July 19, 2018
Impact of Abdominal Aortic Calcification Among Liver Transplantation RecipientsYuki Imaoka, Masahiro Ohira, Ryosuke Nakano, et al.
Plos One|April 13, 2019
A new technology for increasing therapeutic protein levels in the brain over extended periodsRyosuke Nakano, Sayaka Takagi-Maeda, Yuji Ito, et al.
Developmental Biology|May 8, 2019
Cortex glia clear dead young neurons via Drpr/dCed-6/Shark and Crk/Mbc/dCed-12 signaling pathways in the developing Drosophila optic lobeRyosuke Nakano, Masashi Iwamura, Akiko Obikawa, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|April 10, 2008
Pharmacological profile of ASP8497, a novel, selective, and competitive dipeptidyl peptidase-IV inhibitor, in vitro and in vivoYuka Someya, Atsuo Tahara, Ryosuke Nakano, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 8, 2013
[A case of advanced gastric cancer effectively treated with weekly paclitaxel as neoadjuvant chemotherapy]Yasufumi Saito, Masahiro Ikeda, Tadateru Takahashi, et al.
Cancers|February 10, 2024
Impact of KIR-HLA Genotype on Natural-Killer-Cell-Based Immunotherapy for Preventing Hepatocellular Carcinoma after Living-Donor Liver TransplantationNaoki Tanimine, Masahiro Ohira, Emi Kurita, et al.
Journal of Hepato-Biliary-Pancreatic Sciences|July 28, 2018
Polymorphisms in TRAIL predict long-term survival and extrahepatic recurrence following initial hepatectomy for hepatocellular carcinomaYuki Imaoka, Masahiro Ohira, Takuya Yano, et al.
Cancer Medicine|September 25, 2023
The aryl hydrocarbon receptor maintains antitumor activity of liver resident natural killer cells after partial hepatectomy in C57BL/6J miceKoki Sato, Masahiro Ohira, Yuki Imaoka, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2006
Nonfucosylated therapeutic IgG1 antibody can evade the inhibitory effect of serum immunoglobulin G on antibody-dependent cellular cytotoxicity through its high binding to FcgammaRIIIaShigeru Iida, Hirofumi Misaka, Miho Inoue, et al.
Pageof 10

Showing results (31-40 of 94) with videos related to

Sort By:
Pageof 10
Transplant Immunology|November 5, 2024
Association of PIRCHE-II score with anti-donor T-cell response and risk of de novo donor-specific antibody production in kidney transplant recipientsHiroaki Yamane, Kentaro Ide, Yuka Tanaka, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|July 19, 2018
Impact of Abdominal Aortic Calcification Among Liver Transplantation RecipientsYuki Imaoka, Masahiro Ohira, Ryosuke Nakano, et al.
Plos One|April 13, 2019
A new technology for increasing therapeutic protein levels in the brain over extended periodsRyosuke Nakano, Sayaka Takagi-Maeda, Yuji Ito, et al.
Developmental Biology|May 8, 2019
Cortex glia clear dead young neurons via Drpr/dCed-6/Shark and Crk/Mbc/dCed-12 signaling pathways in the developing Drosophila optic lobeRyosuke Nakano, Masashi Iwamura, Akiko Obikawa, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|April 10, 2008
Pharmacological profile of ASP8497, a novel, selective, and competitive dipeptidyl peptidase-IV inhibitor, in vitro and in vivoYuka Someya, Atsuo Tahara, Ryosuke Nakano, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 8, 2013
[A case of advanced gastric cancer effectively treated with weekly paclitaxel as neoadjuvant chemotherapy]Yasufumi Saito, Masahiro Ikeda, Tadateru Takahashi, et al.
Cancers|February 10, 2024
Impact of KIR-HLA Genotype on Natural-Killer-Cell-Based Immunotherapy for Preventing Hepatocellular Carcinoma after Living-Donor Liver TransplantationNaoki Tanimine, Masahiro Ohira, Emi Kurita, et al.
Journal of Hepato-Biliary-Pancreatic Sciences|July 28, 2018
Polymorphisms in TRAIL predict long-term survival and extrahepatic recurrence following initial hepatectomy for hepatocellular carcinomaYuki Imaoka, Masahiro Ohira, Takuya Yano, et al.
Cancer Medicine|September 25, 2023
The aryl hydrocarbon receptor maintains antitumor activity of liver resident natural killer cells after partial hepatectomy in C57BL/6J miceKoki Sato, Masahiro Ohira, Yuki Imaoka, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2006
Nonfucosylated therapeutic IgG1 antibody can evade the inhibitory effect of serum immunoglobulin G on antibody-dependent cellular cytotoxicity through its high binding to FcgammaRIIIaShigeru Iida, Hirofumi Misaka, Miho Inoue, et al.
Pageof 10